How to Help Your Patients Find Cloderm in Stock: A Provider's Guide

If your patients are calling back saying they can't fill their Cloderm prescription, you're not alone. Despite no formal FDA shortage of clocortolone pivalate in 2026, this mid-potency topical steroid has consistent access challenges that ripple back into clinic workflows. This guide is designed to help your practice get ahead of those problems.

Why Are Patients Struggling to Fill Cloderm?

The three main barriers your patients face are:

1. Not stocked locally: Many community pharmacies don't routinely carry clocortolone pivalate because of low prescription volume relative to other topical steroids.
2. Insurance step therapy: Multiple major insurance plans require documented failure of 2 lower-cost topical steroids before approving Cloderm. Without a prior authorization on file, the prescription gets rejected at the pharmacy.
3. High cash price: Brand-name Cloderm retails for $350–$450 per tube. Without insurance or discount programs, many patients simply won't pay that.

Step 1: Set Prescribing Expectations at the Appointment

When prescribing Cloderm, brief the patient or your MA to:

• Tell the patient that clocortolone may not be on the shelf at their usual pharmacy — they may need to call ahead or request a special order.
• Let them know the generic name (clocortolone pivalate) in case they need to ask for it at the pharmacy.
• Inform them of discount options (GoodRx, RxSaver) if they're paying out-of-pocket.

Step 2: Proactively Submit Prior Authorizations

For patients on commercial insurance, submit a prior authorization at the time of prescribing rather than waiting for a rejection. This saves a call-back cycle and ensures the patient can fill their prescription promptly. Key documentation to include:

• Documented history of previous topical steroid failures or adverse reactions
• Specific excipient intolerances (propylene glycol, lanolin, fragrance) if relevant
• Indication (corticosteroid-responsive dermatosis, atopic dermatitis, psoriasis, etc.)
• For pediatric or facial use: note these specifically, as they strengthen the PA rationale

Step 3: Direct Patients to Pharmacy-Finding Tools

Rather than tasking your MA with calling pharmacies, consider directing patients to medfinder. The service calls pharmacies near the patient's location to find which ones can fill their prescription, then sends results by text. This takes the burden off your staff and gives patients a faster resolution.

Step 4: Know When to Bridge or Switch

If a patient is going untreated while you're working on a PA or they can't find the drug locally, bridging with an alternative is appropriate. Best bridging options:

• Triamcinolone acetonide 0.1% cream: Available at virtually every pharmacy, very inexpensive, appropriate for body use.
• Mometasone furoate 0.1% cream: Once-daily dosing, well tolerated, widely available generic.
• Desonide 0.05% cream/ointment: Lower potency (Class 5–6) but appropriate for sensitive skin areas and pediatric patients if Cloderm's potency isn't strictly needed.

Step 5: Document and Communicate Savings Options

For patients paying cash, document in their visit summary that:

• GoodRx coupons can reduce the generic cost to approximately $88.73 at participating pharmacies
• A 90-day mail-order supply may reduce per-dose costs for patients with mail-order insurance benefits
• Patient assistance programs through the manufacturer (EPI Health) may be available for qualifying low-income patients

Summary: Provider Action Checklist

• Set patient expectations at the appointment about potential stocking challenges
• Submit PA proactively for commercial insurance patients
• Direct patients to medfinder or advise them to ask their pharmacy to order it
• Have a bridge alternative ready if the delay is prolonged
• Share GoodRx or manufacturer savings information with cash-pay patients